NEW KINGMAN-BUTLER, Pa., Aug. 26, 2019 /PRNewswire/ -- Christal Dickun, MD with Center for Pain Relief & Longevity is implementing a non-invasive and drug-free solution for Erectile Dysfunction (ED). This cutting-edge procedure boasts a 75% success rate amongst patients. The treatment is called

WEST HARTFORD, Conn., Aug. 26, 2019 /PRNewswire/ -- Dr. Desmond Ebanks with Alternity Healthcare is implementing a non-invasive and drug-free solution for Erectile Dysfunction. This cutting-edge procedure boasts a 75% success rate amongst patients. The treatment is called

MCALLEN, Texas, Aug. 26, 2019 /PRNewswire/ -- Humberto Nunez, MD with Only For Men Health Clinic is implementing a non-invasive and drug-free solution for Erectile Dysfunction (ED). This cutting-edge procedure boasts a 75% success rate amongst patients. The treatment is called

FRISCO, Texas, Aug. 26, 2019 /PRNewswire/ -- Addus HomeCare Corporation (NASDAQ: ADUS), "Addus" or "the Company," a provider of comprehensive home care services, today announced the signing of a definitive agreement to purchase Hospice Partners of America, LLC, a multi-state provider of hospice services, headquartered in Birmingham, Alabama

ABBOTT PARK, Ill., Aug. 26, 2019 /PRNewswire/ -- We know the facts: Girls are less likely to be encouraged to study science, technology, engineering and math. Women who do pursue STEM degrees often don't take related jobs. And when women find work in a STEM industry, many leave within a decade.Abbott (NYSE: ABT) has found a promising way to help address these trends with our high school

INDIANAPOLIS, Aug. 26, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Taltz® (ixekizumab) injection 80 mg/mL for the treatment of adults with active ankylosing spondylitis (AS), also known as radiographic axial spondyloarthritis (r-axSpA).This is the third indicati

THOUSAND OAKS, Calif., Aug. 26, 2019 /PRNewswire/ -- Amgen (NASDAQ: AMGN) announced today that it has entered into an agreement with Celgene Corporation (NASDAQ: CELG) in connection with its previously announced merger with Bristol-Myers Squibb Company (NYSE: BMY) to acquire worldwide rights to Otezla® (apremilast), the only oral, non-bio

IRVINE, Calif., Aug. 26, 2019 /PRNewswire/ -- MDxHealth SA (Euronext: MDXH.BR), a commercial-stage innovative molecular diagnostics company, today announced that Palmetto GBA, a Medicare Administrative Contractor (MAC) that assesses molecular diagnostic technologies under its MolDx program, has issued a draft local coverage determination (LCD) for the SelectMDx

SAN DIEGO, Aug. 26, 2019 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) ("Evofem" or the "Company") today announced the last patient has completed her last visit in AMPREVENCE, the Phase 2b clinical trial evaluating the Company's lead product candidate Amphora®, a Multipurpose Vaginal pH Regulator (MVP-R™), for the p

LAS VEGAS, Aug. 26, 2019 /PRNewswire/ -- As the CDC reports that 69 percent of reported West Nile virus cases have been diagnosed with the more severe neuroinvasive disease,  a scientific paper recently published in the peer-reviewed journal, Nature Communications, offers an explanation as to why some people infected with West Nile virus have no symptoms